Role of human CYP2B6 in S-mephobarbital N-demethylation

Drug Metabolism and Disposition

Volumn 27, Issue 12, 1999, Pages 1429-1433

  Kobayashi, Kaoru ^a,d   Abe, Seiji ^a   Nakajima, Miki ^a,c   Shimada, Noriaki ^b   Tani, Masayoshi ^e   Chiba, Kan ^d   Yamamoto, Toshinori ^a  

^a SHOWA UNIVERSITY   (Japan)

^b Daiichi Pure Chemicals   (Japan)

^c NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^d CHIBA UNIVERSITY   (Japan)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

COUMARIN; CYTOCHROME P450 ISOENZYME; MEPHENYTOIN; METHYLPHENOBARBITAL; N DEMETHYLASE; ORPHENADRINE;

ARTICLE; CATALYSIS; CONTROLLED STUDY; DEMETHYLATION; DRUG METABOLISM; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME KINETICS; HUMAN; HUMAN CELL; LIVER MICROSOME; PRIORITY JOURNAL;

ANTICONVULSANTS; ARYL HYDROCARBON HYDROXYLASES; B-LYMPHOCYTES; CYTOCHROME P-450 ENZYME SYSTEM; DNA, COMPLEMENTARY; HUMANS; KINETICS; MEPHOBARBITAL; METHYLATION; MICROSOMES, LIVER; OXIDOREDUCTASES, N-DEMETHYLATING; STATISTICS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0032726211     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Baker MT, Olson MJ, Wang Y, Ronnenberg JR, Johnson JT and Brady AN (1995) Isofluranechlorodifluroethene interaction in human liver microsomes: Role of cytochrome P4502B6 in potentiation of haloethene metabolism. Drug Metab Dispos 23:60-64.
2. Chang TKH, Weber GF, Crespi CL and Waxman DJ (1993) Differential activation of cyclophosphamide and ifosphamide by cytochrome P-450 2B and 3A in human liver microsomes. Cancer Res 53:5629-5637.
3. Chiba K, Kobayashi K, Manabe K, Tani M, Kamataki T and Ishizaki T (1993a) Oxidative metabolism of omeprazole in human liver microsomes: Cosegregation with S-mephenytoin 4′-hydroxylation. J Pharmacol Exp Ther 266:52-59.
4. Chiba K, Manabe K, Kobayashi K, Takayama Y, Tani M and Ishizaki T (1993b) Development and preliminary application of a simple assay of S-mephenytoin 4-hydroxylase activity in human liver microsomes. Eur J Clin Pharmacol 44:559-562.
5. Eadie MJ, Bochner F, Hooper WD and Tyrer JH (1978) Preliminary observations on the pharmacokinetics of methylphenobarbitone. Clin Exp Neurol 15:131-144.
6. Ekins S, Vandenbranden M, Ring BJ, Gillespie JS, Yang TJ, Gelboin HV and Wrighton SA (1998) Further characterization of the expression in liver and catalytic activity of CYP2B6. J Pharmacol Exp Ther 286:1253-1259.
7. Ekins S, Vandenbranden M, Ring BJ and Wrighton SA (1997) Examination of purported probes of human CYP2B6. Pharmacogenetics 7:165-179.
8. Flammang AM, Gelboin HV, Aoyama T, Gonzalez FJ and McCoy GD (1992) Nicotine metabolism by cDNA-expressed human cylochrome P450s. Biochem Arch 8:1-8.
9. Forrester LM, Henderson CJ, Glancey MJ, Back DJ, Park BK, Ball SE, Kitteringham NR, McLaren AW, Miles JS, Skett P and Wolf CR (1992) Relative expression of cytochrome P450 isoenzymes in human liver and association with the metabolism of drugs and xenobiotics. Biochem J 281:359-368.
10. Granvil CP, Madan A, Sharkawi M, Parkinson A, and Wainer IW (1999) Role of CYP2B6 and CYP3A4 in the in vitro N-dechloroethylation of (R)- and (S)-ifosfamide in human liver microsomes. Drug Metab Dispos 27:533-541.
11. Guengerich FP, Wang P and Davidson NK (1982) Estimation of isozymes of microsomal cytochrome P-450 in rats, rabbits, and humans using immunochemical staining coupled with sodium dodecylsulfate-polyacrylamide gel electrophoresis. Biochemistry 21:1698-1706.
12. Heyn H, White RB and Stevens JC (1996) Catalytic role of cytochrome P4502B6 in the N-demethylation of S-mephenytoin. Drug Metab Dispos 24:948-954.
13. Hooper WD, Kunze HE and Eadie MJ (1981a) Pharmacokinetics and bioavailability of methylphenobarbital in man. Ther Drug Monit 3:39-44.
14. Hooper WD, Kunze HE and Eadie MJ (1981b) Qualitative and quantitative studies of methylphenobarbital metabolism in man. Draft Metab Dispos 9:381-385.
15. Kerremans ALM (1996) Cytochrome P450 isoenzymes - Importance for the internist. Neth J Med 48:237-243.
16. Ko JW, Desta Z and Flockhart DA (1998) Human N-demethylation of (S)-mephenytoin by cytochrome P450s 2C9 and 2B6. Drug Metab Dispos 26:775-778.
17. Kobayashi K, Chiba K, Yagi T, Shimada N, Taniguchi T, Horic T, Tani M, Yamamoto T, Ishizaki T and Kuroiwa Y (1997) Identification of CYP isofomis involved in citalopram N-demethylation by human liver microsomes. J Pharmacol Exp Ther 280:927-933.
18. Kobayashi K, Nakajima M, Chiba K, Yamamoto T, Tani M, Ishizaki T and Kuroiwa Y (1998) Inhibitory effects of antiarrhythmic drugs on phenacetin O-deethylation catalysed by human CYP1A2. Br J Clin Pharmacol 45:361-368.
19. Kunze HE, Hooper WD and Eadie MJ (1980) The metabolism of methylphenobarbitone in man. Asean J Clin Sci 1:115-119.
20. Küpfer A and Branch RA (1985) Stereoselective mephobarbital hydroxylation cosegregates with mephenytoin hydroxylalion. Clin Pharmacol Ther 38:414-418.
21. Küpfer A and Preisig R (1984) Pharmacogenetics of mephenytoin: A new drug hydroxylation polymorphism in man. Eur J Clin Pharmacol 26:753-759.
22. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond) 227:680-685.
23. Miles JS, Bickmore W, Brook JD, McLaren AW, Meehan R and Wolf CR (1989) Close linkage of the human cytochrome P450IIA and P450IIB gene subfamilies: Implications for the assignment of substrate specificity. Nucleic Acids Res 17:2907-2917.
24. Nakajima M, Yamamoto T, Nunoya K, Yokoi T, Nagashima K, Inoue K, Funae Y, Shimada N, Kamataki T and Kuroiwa Y (1996) Role of human cytochrome P4502A6 in C-oxidation of nicotine. Drug Metab Dispos 24:1212-1217.
25. Nelson DR, Koymans L, Kamataki T, Stegeman JJ, Feyereisen R, Waxman DJ, Waterman MR, Gotoh O, Coon MJ, Estabrook RW, Gunsalus IC and Neben DW (1996) P450 superfamily: Update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics 6:1-42.
26. Reidy GF, Methta I and Murray M (1989) Inhibition of oxidative drug metabolism by orphenadrine: In vitro and in vivo evidence for isozyme-specific complexation of cytochrome P-450 and inhibition kinetics. Mol Pharmacol 35:736-743.
27. Rendic S and Di Carlo FJ (1997) Human cytochrome P450 enzymes: A status report summarizing their reactions, substrates, inducers and inhibitors. Drug Metab Rev 29:413-580.
28. Shimada T, Yamazaki H, Mimura M, Inui Y and Guengerich FP (1994) Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: Studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Exp Ther 270:414-423.
29. Stevens JC, White RB, Hsu SH and Martinet M (1997) Human liver CYP2B6-catalyzed hydroxylation of RP 73401. J Pharmacol Exp Ther 282:1389-1395.
30. Sueyoshi T, Kawamoto T, Zelko I, Honkakoski P and Negishi M (1999) The repressed nuclear receptor CAR responds to phenobarbital in activating the human CYP2B6 gene. J Biol Chem 274:6043-6046.
31. Waxman DJ and Azaroff L (1992) Phenobarbital induction of cytochrome P-450 gene expression. Biochem J 281:577-592.
32. Yoshimoto K, Echizen H, Chiba K, Tani M and Ishizaki T (1995) Identification of human CYP isoforms involved in the metabolism of propranolol enantiomers - N-desisopropylation is mediated mainly by CYP1A2. Br J Clin Pharmacol 39:421-431.
33. Yun C-H, Shimada T and Guengerich FP (1991 ) Purification and characterization of human liver microsomal cytochrome P-450 2A6. Mol Pharmacol 40:679-685.